- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Barbara Ryan
Articles
Back in Person, Sparks Could Fly at Upcoming J.P. Morgan Conference
Will biopharma investment heat up and signal better fortunes for 2023?
The New Reality for Industry Dealmaking May be Setting In
Focus is on cash: who’s got it, who doesn’t, and what will it mean?
All About the Rates: The Fallout of Fed Hikes for Biotech
As fundamentals improve, potential rate plateau could ignite growth.
The Biotech Rally Continues—What’s Fueling the Surge?
Biotech stocks and the indexes have staged an impressive recovery.
Has Biotech Bottomed Out—and is Recent Recovery Sustainable?
A look at the driving factors behind renewed optimism.
Biotech Performance Glance—and Promising Ripples for Recovery
A summary of key takeaways from EY’s new Beyond Borders report.